2022 annual financial data
Ultragenyx Pharmaceutical 2022 Operating margin
Direct answer
Operating margin was -178.6%.
Operating income was -648,919,000 USD and net income was -707,421,000 USD.
Operating cash flow was -380,465,000 USD.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 363,329,000 USD
- Operating income
- -648,919,000 USD
- Net income
- -707,421,000 USD
- Operating cash flow
- -380,465,000 USD